As of 2024-12-14, the EV/EBITDA ratio of AVITA Medical Inc (RCEL) is -7.10. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AVITA's latest enterprise value is 359.79 mil USD. AVITA's TTM EBITDA according to its financial statements is -50.69 mil USD. Dividing these 2 quantities gives us the above AVITA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.0x - 16.3x | 14.9x |
| Forward P/E multiples | 14.6x - 17.5x | 15.4x |
| Fair Price | (29.21) - (32.46) | (30.25) |
| Upside | -328.0% - -353.4% | -336.1% |
| Date | EV/EBITDA |
| 2024-12-11 | -7.32 |
| 2024-12-10 | -7.31 |
| 2024-12-09 | -7.56 |
| 2024-12-06 | -7.24 |
| 2024-12-05 | -6.91 |
| 2024-12-04 | -7.12 |
| 2024-12-03 | -7.36 |
| 2024-12-02 | -7.20 |
| 2024-11-29 | -7.10 |
| 2024-11-27 | -7.12 |
| 2024-11-26 | -7.14 |
| 2024-11-25 | -7.23 |
| 2024-11-22 | -7.37 |
| 2024-11-21 | -7.13 |
| 2024-11-20 | -7.22 |
| 2024-11-19 | -7.18 |
| 2024-11-18 | -6.90 |
| 2024-11-15 | -6.65 |
| 2024-11-14 | -6.98 |
| 2024-11-13 | -7.13 |
| 2024-11-12 | -7.02 |
| 2024-11-11 | -6.78 |
| 2024-11-08 | -6.65 |
| 2024-11-07 | -6.89 |
| 2024-11-06 | -6.78 |
| 2024-11-05 | -6.37 |
| 2024-11-04 | -6.25 |
| 2024-11-01 | -5.80 |
| 2024-10-31 | -5.70 |
| 2024-10-30 | -5.85 |
| 2024-10-29 | -5.82 |
| 2024-10-28 | -5.91 |
| 2024-10-25 | -5.71 |
| 2024-10-24 | -5.71 |
| 2024-10-23 | -5.85 |
| 2024-10-22 | -5.98 |
| 2024-10-21 | -5.91 |
| 2024-10-18 | -5.97 |
| 2024-10-17 | -5.89 |
| 2024-10-16 | -6.00 |
| 2024-10-15 | -5.86 |
| 2024-10-14 | -5.86 |
| 2024-10-11 | -5.80 |
| 2024-10-10 | -5.59 |
| 2024-10-09 | -5.71 |
| 2024-10-08 | -5.72 |
| 2024-10-07 | -5.88 |
| 2024-10-04 | -6.07 |
| 2024-10-03 | -6.05 |
| 2024-10-02 | -6.17 |